117 related articles for article (PubMed ID: 20093565)
1. Imaging findings in immunosuppressed patients with Epstein Barr virus-related B cell malignant lymphoma.
Sauter A; Faul C; Bitzer M; Bares R; Kraus S; Fenchel M; Horger M
AJR Am J Roentgenol; 2010 Feb; 194(2):W141-9. PubMed ID: 20093565
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
3. EBV-associated lymphoproliferative disorders: classification and treatment.
Carbone A; Gloghini A; Dotti G
Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
5. Epstein Barr virus-associated lymphoma in HIV-infected children.
Preciado MV; Fallo A; Chabay P; Calcagno L; De Matteo E
Pathol Res Pract; 2002; 198(5):327-32. PubMed ID: 12092768
[TBL] [Abstract][Full Text] [Related]
6. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
7. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
8. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
9. Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient.
Bruce AJ; Subtil A; Rogers RS; Castro LA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e24-8. PubMed ID: 16997090
[TBL] [Abstract][Full Text] [Related]
10. Extranodal malignant lymphoma of the upper aerodigestive tract: prevalence of Epstien-Barr virus (EBV) infection in King Chulalongkorn Memorial Hospital.
Assanasen T; Wannakrairot P; Keelawat S; Ruangvejvorachai P; Pramprayoon N
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S266-73. PubMed ID: 16623040
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
Liebowitz D
N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
[TBL] [Abstract][Full Text] [Related]
12. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
13. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts.
Kleer CG; Tseng MD; Gutsch DE; Rochford RA; Wu Z; Joynt LK; Helvie MA; Chang T; Van Golen KL; Merajver SD
Mod Pathol; 2002 Jul; 15(7):759-64. PubMed ID: 12118114
[TBL] [Abstract][Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
Gibson SE; Hsi ED
Hum Pathol; 2009 May; 40(5):653-61. PubMed ID: 19144386
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.
Linke-Serinsöz E; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2017 Jul; 34(4):352-363. PubMed ID: 28506687
[TBL] [Abstract][Full Text] [Related]
17. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
Miyauchi K; Urano E; Yoshiyama H; Komano J
Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation and lymphoma in humans.
Ponce RA; Gelzleichter T; Haggerty HG; Heidel S; Holdren MS; Lebrec H; Mellon RD; Pallardy M
J Immunotoxicol; 2014; 11(1):1-12. PubMed ID: 23746314
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
